Literature DB >> 11405402

Brugada syndrome and supraventricular tachyarrhythmias: a novel association?

L Eckardt1, P Kirchhof, P Loh, E Schulze-Bahr, R Johna, T Wichter, G Breithardt, W Haverkamp, M Borggrefe.   

Abstract

INTRODUCTION: The Brugada syndrome is a distinct form of idiopathic ventricular fibrillation characterized by a unique ECG pattern consisting of a right bundle branch block-like aspect and ST segment elevation in leads V1 to V3. As a high induction rate of ventricular tachyarrhythmias has been reported in Brugada syndrome, we hypothesized that this also may be true for supraventricular tachycardias in these patients. METHODS AND
RESULTS: Between January 1995 and December 2000, we identified 35 consecutive patients with Brugada syndrome; 26 had a history of cardiac arrest or syncope and 9 were asymptomatic. All patients underwent electrophysiologic study, including an atrial and ventricular stimulation protocol. Ten patients (29%) were found to have supraventricular tachyarrhythmias (SVT) in addition to the Brugada syndrome. These 10 patients presented with aborted sudden cardiac death (n = 3) and/or a family history of sudden cardiac death (n = 4), syncope (n = 4), or primarily with a Brugada typical ECG, a positive family history, and palpitations (n = 2). Eight of them underwent genetic testing, but only 1 had a mutation in the SCN5A gene. In 6 patients, an AV nodal reentrant tachycardia was easily and reproducibly inducible. Two patients had clinical documented and inducible episodes of an atrial tachycardia (1 in addition to an AV nodal reentrant tachycardia). One patient had paroxysmal atrial fibrillation alternating with sinus rhythm, and 2 patients with accessory pathways were identified.
CONCLUSION: This is the first description of an association of the Brugada syndrome with SVT. Thus, the arrhythmogenic substrate in Brugada syndrome may not be restricted to the ventricular level. Palpitations in this syndrome should raise the possibility of SVT. Conversely, in patients with SVT and aborted sudden cardiac death or syncope not related to SVT, the Brugada syndrome should be considered a possible additional electrophysiologic abnormality.

Entities:  

Mesh:

Year:  2001        PMID: 11405402     DOI: 10.1046/j.1540-8167.2001.00680.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  32 in total

1.  Brugada syndrome associated with supraventricular tachycardia: diagnostic and therapeutic strategies.

Authors:  S Paraskevaidis; V Kamperidis; E Theofilogiannakos; Y S Chatzizisis; V Vassilikos; A Boufidou; G Stavropoulos; G Dakos; S Gavrielidis; I Styliadis
Journal:  Herz       Date:  2010-10-28       Impact factor: 1.443

Review 2.  Brugada syndrome.

Authors:  Johnson Francis; Charles Antzelevitch
Journal:  Int J Cardiol       Date:  2005-05-25       Impact factor: 4.164

3.  Coexistence of atrioventricular accessory pathways and drug-induced type 1 Brugada pattern.

Authors:  Can Hasdemir; Jimmy Jyh-Ming Juang; Sedat Kose; Umut Kocabas; Mehmet N Orman; Serdar Payzin; Hatice Sahin; Candan Celen; Emin E Ozcan; Ching-Yu Julius Chen; Ramazan Gunduz; Oguzhan E Turan; Oktay Senol; Elena Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2018-07-16       Impact factor: 1.976

Review 4.  The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Authors:  Johannes Steinfurt; Jürgen Biermann; Christoph Bode; Katja E Odening
Journal:  Dtsch Arztebl Int       Date:  2015-06-05       Impact factor: 5.594

Review 5.  Brugada syndrome: current clinical aspects and risk stratification.

Authors:  Takanori Ikeda
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

6.  T wave alternans does not assess arrhythmic risk in patients with Brugada syndrome.

Authors:  Paulus Kirchhof; Lars Eckardt; Sascha Rolf; Hans-D Esperer; Matthias Paul; Thomas Wichter; Helmut U Klein; Günter Breithardt; Dirk Böcker
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

Review 7.  Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease.

Authors:  Ijaz A Khan; Chandra K Nair
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

8.  Brugada syndrome: Controversies in Risk stratification and Management.

Authors:  Lm Nunn; J Bhar-Amato; Pd Lambiase
Journal:  Indian Pacing Electrophysiol J       Date:  2010-09-05

Review 9.  Atrial fibrillation and Brugada syndrome.

Authors:  Johnson Francis; Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2008-03-25       Impact factor: 24.094

10.  Prevention of inappropriate ICD shocks in patients with Brugada syndrome.

Authors:  Christian Veltmann; Juergen Kuschyk; Rainer Schimpf; Florian Streitner; Nina Schoene; Martin Borggrefe; Christian Wolpert
Journal:  Clin Res Cardiol       Date:  2009-09-16       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.